Barr Pharmaceuticals says to market generic of Lamisil

(Reuters) - Gedeon Richter received final U.S. Food and Drug Administration approval to manufacture and market a generic version of Lamisil, Barr said in a statement.



Barr plans to launch the product immediately.


Read more at Reuters.com Government Filings News